ADAM19 Activators belong to a distinctive chemical class renowned for their capacity to modulate the activity of ADAM19, an integral member of the ADAM (a disintegrin and metalloproteinase) family of enzymes. These activators are characterized by their specific interactions with the catalytic domain of ADAM19, orchestrating a series of molecular events that culminate in the activation of this metalloproteinase. ADAM19 itself plays a pivotal role in cellular processes by mediating the proteolytic cleavage of various membrane-bound substrates, thereby influencing cell signaling, adhesion, and migration.
The chemical entities identified as ADAM19 Activators exhibit a remarkable ability to induce conformational changes in the ADAM19 catalytic domain, promoting its enzymatic activity. Through precise binding interactions, these activators act as allosteric modulators, enhancing the substrate accessibility of ADAM19 and facilitating its role in diverse cellular functions. The structural features of ADAM19 Activators are designed to target specific regions of the enzyme, promoting a controlled and temporally regulated activation. Understanding the intricate details of the interaction between these activators and ADAM19 at the molecular level holds significant promise for unraveling the complex network of cellular events orchestrated by ADAM family members, contributing to the broader comprehension of cellular signaling and molecular mechanisms involved in physiological and pathological processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), a crucial player in the regulation of ADAMs. Through PKC activation, PMA can theoretically lead to increased ADAM19 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylyl cyclase activator, which can increase cAMP levels. cAMP is known to regulate ADAMs and can therefore potentially enhance ADAM19 activity through this mechanism. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, it can increase phosphorylation levels, potentially enhancing the activity of ADAM19, as ADAMs' activity is often regulated by phosphorylation. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits CRM1/exportin-1, affecting nuclear export. It indirectly influences ADAMs by altering the cellular location of regulatory proteins, potentially enhancing ADAM19 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC. As PKC is involved in regulating ADAMs, staurosporine can indirectly affect ADAM19 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium Orthovanadate is a potent inhibitor of protein tyrosine phosphatases, which can increase tyrosine phosphorylation levels. Given that ADAMs' activity is often regulated by phosphorylation, this compound could enhance ADAM19 function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can affect multiple pathways, including those involving ADAMs. Through these influences, genistein can potentially enhance ADAM19 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. JNK signaling has been implicated in the regulation of ADAMs, potentially allowing anisomycin to enhance ADAM19 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is part of the MAPK pathway. As the MAPK pathway can regulate ADAMs, this compound could indirectly enhance ADAM19 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K signaling is known to regulate ADAMs, and thus this compound could potentially enhance ADAM19 function. | ||||||